Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Jul 8;3(9):418-421.
doi: 10.1016/j.hrcr.2017.06.008. eCollection 2017 Sep.

Cardiac sarcoidosis mimicking arrhythmogenic right ventricular dysplasia in a patient presenting with monomorphic ventricular tachycardia

Ross Biggs  1 , Brijesh Patel  2 , Matthew W Martinez  2 , Matthew McCambridge  3 , Susan Kim  4 , Norman Marcus  2
Affiliations
Case Reports

Cardiac sarcoidosis mimicking arrhythmogenic right ventricular dysplasia in a patient presenting with monomorphic ventricular tachycardia

Ross Biggs et al. HeartRhythm Case Rep. .
No abstract available

Keywords: Arrhythmogenic right ventricular dysplasia; Cardiac sarcoidosis; Monomorphic ventricular tachycardia; Ventricular arrhythmia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Initial electrocardiogram tracing notable for an epsilon wave in V1, a QRS of 140 ms, and T-wave inversions in V1–V5, all consistent with the diagnosis of arrhythmogenic right ventricular dysplasia.
Figure 2
Figure 2
4 chamber view echocardiogram with color doppler demonstrating marked right atrial and ventricular enlargement. Tricuspid annular dilatation with secondary, moderate tricuspid regurgitation is also noted.
Figure 3
Figure 3
A: Transverse fluorodeoxyglucose positron emission tomography computed tomography (FDG-PET CT) demonstrating diffuse uptake within the left ventricular myocardium and patchy uptake within the right ventricular myocardium. B: Repeat transverse FDG-PET CT imaging demonstrating nearly complete resolution of FDG uptake within the right and left ventricular myocardium after the addition of mycophenolate mofetil therapy.
Supplementary Figure 1
Supplementary Figure 1
Supplementary Figure 2
Supplementary Figure 2
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Koplan B.A., Stevenson W.G. Ventricular tachycardia and sudden cardiac death. Mayo Clin Proc. 2009;84:289–297. - PMC - PubMed
    1. Tabib A., Loire R., Chalabreysse L. Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia. Circulation. 2003;108:3000–3005. - PubMed
    1. Mehta D., Mori N., Goldbarg S.H., Lubitz S., Wisnivesky J.P., Teirstein A. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation. Circ Arrhythm Electrophysiol. 2011;4:43–48. - PubMed
    1. Romero J., Mejia-Lopez E., Manrique C., Lucariello R. Arrhythmogenic right ventricular cardiomyopathy (ARVC/D): a systematic literature review. Clin Med Insights Cardiol. 2013;7:97–114. - PMC - PubMed
    1. Patel B., Shah M., Gelaye A. A complete heart block in a young male: a case report and review of literature of cardiac sarcoidosis. Heart Fail Rev. 2017;22:55. - PubMed

Publication types

LinkOut - more resources